Previously, DM1 was considered a chronic and single autoimmune disease, classically characterized by a deficiency in insulin production due to a T-cell mediated attack on insulin-producing pancreatic β-cells, which resulted in hyperglycemia. The gene discussed is INS; the disease is Hyperglycemia.